A historical argument for regulatory failure in the case of Primodos and other hormone pregnancy tests

The drug Primodos and other hormone pregnancy tests (HPTs) remained on the British market for about a decade after they were first implicated, in 1967, as a possible cause of birth defects. In November 2017, an expert working group (EWG) set up by the Medicines and Healthcare Products Regulatory Age...

Descripción completa

Detalles Bibliográficos
Autores principales: Olszynko-Gryn, Jesse, Bjørvik, Eira, Weßel, Merle, Jülich, Solveig, Jean, Cyrille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
History
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234516/
https://www.ncbi.nlm.nih.gov/pubmed/30456319
http://dx.doi.org/10.1016/j.rbms.2018.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234516/
https://www.ncbi.nlm.nih.gov/pubmed/30456319
http://dx.doi.org/10.1016/j.rbms.2018.09.003

Ejemplares similares